Frankrike -
fransk -
ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)
ultratard 40 u.i./ml, suspension injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante zinc cristalline - suspension - 40 ui - composition pour 1 ml > insuline humaine recombinante zinc cristalline : 40 ui
Italia -
italiensk -
AIFA (Agenzia Italiana del Farmaco)
ultratard hm
novo nordisk a/s - insulina (umana) - insulina (umana)
Hellas -
gresk -
Εθνικός Οργανισμός Φαρμάκων
ultratard -100iu/ml 100 iu/ml inj.susp
novo nordisk a/s, bagsvaerd, denmark - insulin (human) - ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 100 iu/ml - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ
Slovenia -
slovensk -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
ultratard 40 i.e./ ml
suspenzija za injiciranje - humani insulin
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
ultratard 100iu/ml
novo nordisk a/s - insulin human - suspension for injection
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
ultratard insulin
novo nordisk a/s - 40
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
ultratard insulin
novo nordisk a/s - 80
Irland -
engelsk -
HPRA (Health Products Regulatory Authority)
ultratard mc insulin
novo nordisk a/s - 80 international unit
New Zealand -
engelsk -
Medsafe (Medicines Safety Authority)
ultratard
novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml - suspension for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: hydrochloric acid methyl hydroxybenzoate sodium acetate trihydrate sodium chloride sodium hydroxide water for injection zinc as chloride, approx.
Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ultratard 100unitsml suspension for injection 10ml vials
novo nordisk ltd - insulin zinc suspension crystalline human - suspension for injection - 100unit/1ml